Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Insmed (INSM) PT Raised to $154 at TD Cowen Following Brinsupri Approval
-
Insmed (INSM) PT Raised to $114 at TD Cowen
-
Insmed To Present at March 2025 Investor Conferences
-
TD Cowen Reiterates Buy Rating on Insmed (INSM)
-
Insmed (INSM) PT Raised to $98 at TD Cowen
-
TD Cowen Reiterates Buy Rating on Insmed (INSM)
-
Insmed (INSM) PT Raised to $67 at TD Cowen
-
TD Cowen Reiterates Buy Rating on Insmed (INSM)
-
Insmed To Present at Three March Conferences
-
Insmed To Present at Two March Conferences
-
Insmed To Present at the Cowen 42nd Annual Health Care Conference
-
Insmed to Present at Two March Conferences
-
Insmed to Present at the Cowen and Company 40th Annual Health Care Conference
-
Insmed (INSM) PT Raised to $56 at Cowen
-
Insmed to Present at the Cowen and Company 38th Annual Health Care Conference
-
Cowen Sets 'Street High' $54 PT on Insmed (INSM) Following CONVERT Top-Line
-
Insmed to Present at the Cowen and Company 37th Annual Health Care Conference
-
Insmed to Present at the 36th Annual Cowen & Company Healthcare Conference
-
US NTM Delayed Up to 12 Months; Cowen Cuts Price Target on Insmed (INSM) to $34
-
UPDATE: Cowen Starts Insmed (INSM) at Outperform
-
Streetinsider.com Pre-Open Movers 07/16: (SHFL) (SOL) (POWI) Higher; (LQDT) (JOEZ) (HSII) Lower (more...)

